Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Receivables (2020 - 2025)

Agilon Health's Receivables history spans 6 years, with the latest figure at $673.8 million for Q4 2025.

  • For Q4 2025, Receivables fell 33.75% year-over-year to $673.8 million; the TTM value through Dec 2025 reached $673.8 million, down 33.75%, while the annual FY2025 figure was $673.8 million, 33.75% down from the prior year.
  • Receivables reached $673.8 million in Q4 2025 per AGL's latest filing, down from $947.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.6 billion in Q1 2024 to a low of $288.8 million in Q1 2021.
  • Average Receivables over 5 years is $880.3 million, with a median of $947.1 million recorded in 2023.
  • Peak YoY movement for Receivables: surged 133.21% in 2023, then crashed 33.75% in 2025.
  • A 5-year view of Receivables shows it stood at $293.9 million in 2021, then surged by 69.87% to $499.3 million in 2022, then skyrocketed by 89.69% to $947.1 million in 2023, then grew by 7.39% to $1.0 billion in 2024, then plummeted by 33.75% to $673.8 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Receivables are $673.8 million (Q4 2025), $947.2 million (Q3 2025), and $1.0 billion (Q2 2025).